Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2018

01-08-2018 | Correction

Correction to: Dysplastic features seen in a patient with acute myeloid leukemia harboring the KMT2A-TET1 fusion gene

Authors: Hidetsugu Kawai, Hiromichi Matsushita, Yasuyuki Aoyama, Keiko Matsui, Makoto Onizuka, Kiyoshi Ando

Published in: International Journal of Hematology | Issue 2/2018

Login to get access

Excerpt

In the original publication of the article, the title was incorrectly published as “Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene”. The correct title should be “Dysplastic features seen in a patient with acute myeloid leukemia harboring the KMT2A-TET1 fusion gene”. …
Metadata
Title
Correction to: Dysplastic features seen in a patient with acute myeloid leukemia harboring the KMT2A-TET1 fusion gene
Authors
Hidetsugu Kawai
Hiromichi Matsushita
Yasuyuki Aoyama
Keiko Matsui
Makoto Onizuka
Kiyoshi Ando
Publication date
01-08-2018
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2018
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2476-5

Other articles of this Issue 2/2018

International Journal of Hematology 2/2018 Go to the issue

Original Article

A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP)

Original Article

A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors

Correction

Correction to: Atypical erythroblastosis in a patient with Diamond–Blackfan anemia who developed del(20q) myelodysplasia

Original Article

Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

Original Article

Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center

Case Report

Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits